XML 14 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Operating expenses:        
Research and development $ 7,804,921 $ 682,588 $ 10,409,502 $ 1,653,922
General and administrative 6,285,597 197,441 7,058,345 660,642
Total operating expenses 14,090,518 880,029 17,467,847 2,314,564
Loss from operations (14,090,518) (880,029) (17,467,847) (2,314,564)
Interest income (expense), net 41,778 (919,805) (1,170,742) (2,647,530)
Net loss $ (14,048,740) $ (1,799,834) $ (18,638,589) $ (4,962,094)
Net loss per common share:        
Basic and diluted net loss per common share (restated) (in dollars per share) $ (1.59) $ (10.46) $ (6.04) $ (29.15)
Basic and diluted weighted average number of common shares outstanding (restated) 8,847,155 172,045 3,087,588 170,227